| Valerie Carregal Augello, DO | |
|
2100 Pennsylvania Ave Nw Ste A, Washington, DC 20037-3202 | |
| (202) 861-8888 | |
| (202) 861-8887 |
| Full Name | Valerie Carregal Augello |
|---|---|
| Gender | Female |
| Speciality | Allergy & Immunology - Clinical & Laboratory Immunology |
| Location | 2100 Pennsylvania Ave Nw Ste A, Washington, District Of Columbia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477576791 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207KI0005X | Allergy & Immunology - Clinical & Laboratory Immunology | MD31422 (District Of Columbia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Valerie Carregal Augello, DO 2100 Pennsylvania Ave Nw Ste A, Washington, DC 20037-3202 Ph: (202) 861-8888 | Valerie Carregal Augello, DO 2100 Pennsylvania Ave Nw Ste A, Washington, DC 20037-3202 Ph: (202) 861-8888 |
News Archive
In this Foreign Policy Association blog post, freelance writer Julia Robinson calls for individuals to start demanding more action on non-communicable diseases (NCDs), writing, "It is possible to have stronger responses to NCDs" than those presented in the political declaration that resulted from last month's U.N. High-level Meeting (HLM) on NCDs, such as the smoking bans, requirements for posting nutrition information in restaurants and trans fat restrictions enacted in New York City by Mayor Michael Bloomberg.
Medivir announced today 24-week end-of-treatment interim results from the 5-arm phase 2b response guided PILLAR study in 386 treatment-naïve patients with hepatitis C virus (HCV) genotype-1 (TMC435-C205).
An enzyme identified in Saccharomyces cerevisiae, commonly known as brewer's or baker's yeast, has passed in vitro trials, demonstrating its capacity to kill acute lymphoblastic leukemia (ALL) cells.
On May 21, 2010, Kathleen Sebelius, Secretary of Health and Human Services announced the addition of Severe Combined Immunodeficiency - commonly known as bubble boy disease - to the core panel of 29 genetic disorders - as part of her recommendation to adopt the national Recommended Uniform Screening Panel.
"The United Nations Children's Fund [on Friday] warned that it may be forced to stop humanitarian assistance to more than 100,000 Syrian refugees in Jordan due to insufficient funds," the U.N. News Centre reports.
› Verified 6 days ago
Chioma Udemgba, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 315 H St Ne Ste A, Washington, DC 20002 Phone: 202-975-0100 | |
Eliane Abou-jaoude, Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 2600 Virginia Ave Nw Ste 508, Washington, DC 20037 Phone: 202-342-1984 | |
Mary Mcnerney Klote, MD Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 6900 Georgia Ave Nw, Room 1j - Allergy, Washington, DC 20307 Phone: 202-782-6848 Fax: 202-782-7093 | |
Alicia Catherine Trotter, M.D. Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 3301 New Mexico Ave Nw, #302, Washington, DC 20016 Phone: 202-966-2222 Fax: 202-686-7079 | |
Christopher B Soltis, M.D. Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: Bldg 2 Wramc Room 1j69, 6900 Georgia Ave. Nw, Washington, DC 20307 Phone: 202-782-6848 | |
Dr. Vanessa Bundy, MD, PHD Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 111 Michigan Ave Nw, Washington, DC 20010 Phone: 202-476-3016 Fax: 202-849-4831 | |
Dr. Laurie Joan Smith, MD Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 6900 Georgia Ave, Allergy Clinic 1j96 Walter Reed Army Medical Center, Washington, DC 20906 Phone: 202-782-7634 Fax: 202-782-7093 |